Guadecitabine improved relapse-free survival in high-risk acute myeloid leukemia and myelodysplastic syndrome patients after transplant: phase II results from a single center
移植后,Guadecitabine 改善了高危急性髓系白血病和骨髓增生异常综合征患者的无复发生存期:单中心 II 期临床试验结果
期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2025.287628
Oran, Betül; Thall, Peter; Alousi, Amin; Al-Atrash, Gheath; Mehta, Rohtesh; Marin, David; Kebriaei, Partow; Popat, Uday; Bassett, Roland; Bashir, Qaiser; Im, Jin; Olson, Amanda; Jewell, Jessica; Smallbone, Portia; Shpall, Elizabeth; Champlin, Richard